INTELLIPHARMACEUTICS INTL INCINTELLIPHARMACEUTICS INTL INCINTELLIPHARMACEUTICS INTL INC

INTELLIPHARMACEUTICS INTL INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪3.33 M‬CAD
‪34.42 M‬
Beta (1Y)
−0.31

About INTELLIPHARMACEUTICS INTL INC


CEO
Isa Odidi
Headquarters
Toronto
Founded
1998
FIGI
BBG000BLSSY1
Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a controlled-release drug delivery platform that can be applied to the development of pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company was founded by Isa Odidi and Amina Odidi in 1998 and is headquartered in Toronto, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of IPCI.H is 0.080 CAD — it has decreased by −11.11% in the past 24 hours. Watch INTELLIPHARMACEUTICS INTL INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange INTELLIPHARMACEUTICS INTL INC stocks are traded under the ticker IPCI.H.
IPCI.H reached its all-time high on Nov 20, 2013 with the price of 670.000 CAD, and its all-time low was 0.040 CAD and was reached on Jun 21, 2023. View more price dynamics on IPCI.H chart.
See other stocks reaching their highest and lowest prices.
IPCI.H stock is 18.75% volatile and has beta coefficient of −0.31. Track INTELLIPHARMACEUTICS INTL INC stock price on the chart and check out the list of the most volatile stocks — is INTELLIPHARMACEUTICS INTL INC there?
Today INTELLIPHARMACEUTICS INTL INC has the market capitalization of ‪2.80 M‬, it has increased by 15.38% over the last week.
Yes, you can track INTELLIPHARMACEUTICS INTL INC financials in yearly and quarterly reports right on TradingView.
INTELLIPHARMACEUTICS INTL INC is going to release the next earnings report on Jan 29, 2025. Keep track of upcoming events with our Earnings Calendar.
No, IPCI.H doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IPCI.H shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INTELLIPHARMACEUTICS INTL INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INTELLIPHARMACEUTICS INTL INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INTELLIPHARMACEUTICS INTL INC stock shows the sell signal. See more of INTELLIPHARMACEUTICS INTL INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.